infliximab Injection [Inflectra]

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
0120132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • 2018
NEW YORK--(BUSINESS WIRE)--New data show that switching patients with Crohn’s disease (CD) to INFLECTRA (infliximab CTP13) from… (More)
Is this relevant?
Review
2017
Review
2017
s of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation S247 from the UK Inflammatory Bowel Disease (IBD… (More)
Is this relevant?
Review
2016
Review
2016
In the last 20 years, the advent of anti-tumor necrosis factor alpha (TNFα) biologics has revolutionized the treatment of… (More)
  • table 1
Is this relevant?
Review
2015
Review
2015
INTRODUCTION Biosimilars are biologic products that receive authorization based on an abbreviated regulatory application… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2013
Review
2013
BACKGROUND A biosimilar is a copy version of an approved original biological medicine whose data protection has expired. AIM To… (More)
Is this relevant?